Cervical Cerclage for Preventing Spontaneous Preterm Birth in Singleton Pregnancies Without Prior Spontaneous Preterm Birth and With Short Transvaginal Ultrasound Cervical Length

April 18, 2016 updated by: Gabriele Saccone, Federico II University

Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB.

Different strategies have been adopted for prevention of SPTB. Growing interest has focused on pessary for prevention of SPTB. Cervical pessary is relatively non-invasive, easy to use, does not require anesthesia, can be used in an outpatient clinic setting, and it is easily removed when necessary. However, a recent systematic review and meta-analysis of randomized clinical trials showed that in singleton pregnancies with short cervix, prophylactic use of the pessary did not reduce the rate of spontaneous preterm delivery or improve perinatal outcome. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of women with both prior SPTB and TVU CL ≤25mm. Interestingly, only 235 singletons without prior SPTB,7 and 504 singletons gestations with prior SPTB,6 have been included in randomized studies on cerclage for TVU CL ≤25mm. A meta-analysis of four trials showed that cervical cerclage did not prevent SPTB in women with short TVU CL and without prior preterm birth.7 However, even if the statistical significance were not reached, they found a reduction in SPTB <35 weeks by 16% in singletons with short TVU CL and without prior SPTB (20.6% vs 31.2%; relative risk (RR) 0.84, 95% confidence interval (CI) 0.60 to 1.17) and by 24% in singletons without risk factors for SPTB (25.6% vs 33.3%; RR 0.76, 95% CI 0.52 to 1.15).

Therefore, the aim of this study is to evaluate the efficacy of cervical cerclage in prevention of SPTB in singleton pregnancies with short TVU CL in second trimester, without prior SPTB.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Investigators aim to conduct a prospective, multicenter, randomized, open-label, clinical trial at Department of Reproductive Science, University of Naples Federico II. All women included in the study will provide a written informed consent to participate in the study before the randomization.

Women with TVU CL ≤25mm who will meet the inclusion criteria will be counselled by an obstetrician regarding the risk of SPTB as per standard of care. The patient will be given ample time to have all questions addressed and consider participation. If the patient agrees to participate in the study, the informed consent form will be signed and a copy will be given to the patient. Women who are eligible and consent to participate in the study will be randomly assigned to one of two groups: cervical cerclage (i.e. intervention group) or standard obstetric management (i.e. control group).

Investigators planned subgroup analyses according to different CL cutoffs (i.e. <=15 and <=10 mm); type of suture; and according to prior history of cervical surgery (i.e. LEEP or cone biopsy).

Study Type

Interventional

Enrollment (Anticipated)

587

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • 18-50 ages
  • Singleton pregnancy
  • Cervical length <=25mm between 18(0) and 23(6) weeks

Exclusion Criteria:

  • Multiple pregnancy
  • Prior spontaneous preterm birth or second trimester losses between 16(0) and 36(6) weeks
  • Cerclage in situ
  • Painful regular uterine contraction and/or preterm labor
  • Ruptured membranes
  • Major fetal defects
  • Active vaginal bleeding
  • Placenda previa and/or accreta
  • Cervical dilation >1.5 cm and/or visible membranes by pelvic exam
  • Suspicion of chorioamnionitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cervical cerclage
After the woman is placed in the dorsal lithotomy position and the bladder is emptied with a urinary catheter to reduce the chance of bladder injury, surgical preparation with Betadine will be performed. Breisky retractors and Sims retractors will be used to exposure the entire cervix. Sponge ring forceps will be used to optimized visualization of the cervix and provide the necessary countertraction at the suture entry and exit sites. McDonald technique will be performed placing 4-6 bites circumferentially around the cervix. Only one stitch will be used. The suture will be places as high as feasible
McDonald cervical cerclage
No Intervention: No intervention
Bed rest will be not recommended.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Spontaneous preterm birth (SPTB)
Time Frame: Less than 35 weeks gestation
Less than 35 weeks gestation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
neonatal mortality
Time Frame: Between birth and 28 days of age
death of a live-born baby within the first 28 days of life
Between birth and 28 days of age
Spontaneous preterm birth (SPTB)
Time Frame: Less than 37,34,32,28 and 24 weeks gestation
Less than 37,34,32,28 and 24 weeks gestation
Gestational age at delivery
Time Frame: Delivery (at birth)
mean gestational age at delivery in weeks
Delivery (at birth)
Latency
Time Frame: Delivery (at birth)
mean latency in days (from randomization to delivery)
Delivery (at birth)
chorioamnionitis
Time Frame: Delivery (at birth)
chorioamnionitis histologically proven
Delivery (at birth)
Birth weight
Time Frame: Delivery (at birth)
in grams
Delivery (at birth)
Admission to neonatal intensive care unit
Time Frame: Delivery (at birth)
Delivery (at birth)
respiratory distress syndrome
Time Frame: Delivery (at birth)
Delivery (at birth)
low birth weight
Time Frame: Delivery (at birth)
birth weight <2500 grams
Delivery (at birth)
intraventricular hemorrhage
Time Frame: Between birth and 28 days of age
grade 3 or 4
Between birth and 28 days of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2016

Primary Completion (Anticipated)

April 1, 2018

Study Completion (Anticipated)

April 1, 2019

Study Registration Dates

First Submitted

April 8, 2016

First Submitted That Met QC Criteria

April 18, 2016

First Posted (Estimate)

April 21, 2016

Study Record Updates

Last Update Posted (Estimate)

April 21, 2016

Last Update Submitted That Met QC Criteria

April 18, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 100/16

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Birth

Clinical Trials on Cervical cerclage

Subscribe